Uw winkelwagen is leeg
Begin met het toevoegen van onderzoekspeptiden aan uw winkelwagen.
PRODUCTEN BEKIJKENAdvanced NAD+ Delivery System

QUICK ANSWER
NovaDose NAD+ (advanced nad+ delivery system) is a pharmaceutical-grade research compound. NovaDose delivers pharmaceutical-grade NAD+ through an innovative cartridge-based pen system. The auto-injection pen contains 1000mg NAD+ delivered through 2 cartridges with adjustable dose settings (10-100mg). ORYN delivers NovaDose NAD+ in a cartridge-based delivery system starting from EUR 299. All products are for research purposes only.
MOLECULAR PROFILE
FORMULA
C21H27N7O14P2
WEIGHT
663.43 Da
CLASSIFICATION
Dinucleotide Coenzyme / Metabolic Cofactor
STUDIES CITED
4 key studies
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every living cell, functioning as a critical electron carrier in cellular metabolism. In its oxidised form (NAD+), it accepts electrons from metabolic reactions; in its reduced form (NADH), it donates them to the electron transport chain for ATP production. This redox cycling is fundamental to energy metabolism — without NAD+, cells cannot convert food into usable energy.
READ FULL MECHANISM →2013
Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging
Demonstrated that restoring NAD+ levels in aged mice reversed mitochondrial dysfunction and restored nuclear-mitochondrial communication to youthful levels.
2016
NAD+ repletion improves mitochondrial and stem cell function and enhances lifespan in mice
Showed NAD+ supplementation improved muscle stem cell function, increased mitochondrial activity, and extended lifespan in aged mice.
2021
NAD+ metabolism and its roles in cellular processes during ageing
Comprehensive review establishing the central role of NAD+ decline in age-related diseases and the therapeutic potential of NAD+ replenishment strategies.
2016
CD38 dictates age-related NAD+ decline and mitochondrial dysfunction
Identified the enzyme CD38 as the primary driver of age-related NAD+ depletion, increasing 2-3 fold with age and consuming cellular NAD+ stores.
NAD+ was discovered in 1906 by Arthur Harden and William Young during their studies of yeast fermentation, making it one of the oldest known biological molecules. Hans von Euler-Chelpin received the Nobel Prize in Chemistry in 1929 for elucidating its role in fermentation, and subsequent Nobel-winning work by Otto Warburg (1931) and Arthur Kornberg (1959) further characterised its metabolic functions.
FULL RESEARCH HISTORY →
NovaDose delivers pharmaceutical-grade NAD+ through an innovative cartridge-based pen system. The auto-injection pen contains 1000mg NAD+ delivered through 2 cartridges with adjustable dose settings (10-100mg). Includes pen, 2x NAD+ cartridges, and premium carrying case. Designed for sustained NAD+ research protocols.
NAD+ CONTENT
1000 mg total
DELIVERY SYSTEM
Auto-injection pen + 2 cartridges
TOTAL VOLUME
6 mL
DOSE SETTINGS
1-5 (10-100 mg)
BIOAVAILABILITY
Near 100%
FORMULATION
NAD+, L-Carnitine, Taurine, Reduced Glutathione
PEPTIDE RESEARCH
A comprehensive exploration of NAD+ — the essential coenzyme at the heart of cellular energy, DNA repair, and longevity research. From molecular mechanisms to optimal delivery methods.
10 min read
PEPTIDE RESEARCH
A comprehensive guide to the leading metabolic and weight-loss peptides available for research in the UK. Compare mechanisms, efficacy data, and delivery systems.
9 min read
GUIDES
Proper peptide storage is critical for maintaining potency and research reliability. Learn the best practices for temperature control, shelf life management, and safe transport.
7 min read
RESEARCH GUIDES
A detailed comparison of NAD+ delivery methods: traditional IV drip therapy versus modern subcutaneous injection pen systems like ORYN's NAD+ pen and NovaDose.
8 min read
EDUCATION
Everything you need to know about peptide pen delivery systems — what they are, how they work, advantages over vials, and why they're the future of peptide research.
6 min read
EDUCATION
An evidence-based comparison of research peptides and hormone replacement therapy. Understanding the fundamental differences in mechanism, regulation, safety, and research applications.
10 min read
COMPARISON
Both systems deliver 500mg of pharmaceutical-grade NAD+ and are vastly superior to IV therapy in cost and convenience. The NAD+ Pen (€189) offers adjustable dosing and a lower price point. The NovaDose (€299) offers the most advanced delivery with daily microdosing precision and near-100% bioavailability. Choose the Pen for flexibility, or the NovaDose for the most advanced delivery technology.
COMPARISON
NAD+ pen systems offer comparable bioavailability to IV therapy at a fraction of the cost and without clinic visits. ORYN's standard NAD+ pen (€189) and NovaDose system (€299) both deliver pharmaceutical-grade NAD+ with the convenience of at-home administration.
COMPARISON
NAD+ and Glutathione address two different pillars of cellular health. NAD+ is essential for energy production, DNA repair, and sirtuin activation — the metabolic side of ageing. Glutathione is the body's master antioxidant, defending against oxidative damage, supporting detoxification, and regulating melanin. Both decline with age, making their combination one of the most comprehensive anti-ageing research protocols available.
COMPARISON
The MediT Pen and NovaDose represent ORYN's two advanced delivery platforms, each optimised for different compounds and dosing philosophies. The MediT Pen delivers Tirzepatide in a prefilled weekly format — maximum convenience for metabolic research. The NovaDose delivers NAD+ via an advanced cartridge system for daily microdosing — maximum precision for cellular energy research. They are complementary systems serving different research needs.
COMPARISON
BPC-157 and NAD+ support recovery through completely different biological layers. BPC-157 directly repairs damaged tissue — tendons, gut lining, nerves — through growth factor modulation and angiogenesis. NAD+ restores the cellular energy and DNA repair capacity needed for all recovery processes. BPC-157 fixes the damage; NAD+ powers the machinery that enables repair. Together, they create one of the most comprehensive recovery protocols available.
COMPARISON
GHK-Cu and NAD+ are both powerful anti-ageing compounds, but they target entirely different ageing mechanisms. GHK-Cu addresses the visible signs of ageing — skin laxity, wrinkles, thinning hair, and slow wound healing — by stimulating structural protein production. NAD+ addresses the invisible, cellular foundations of ageing — declining energy production, accumulating DNA damage, and silenced longevity genes. For comprehensive anti-ageing research, the combination covers both the structural and metabolic dimensions of age-related decline.
COMPARISON
NAD+ is the superior choice for cellular energy production, sirtuin activation, and DNA repair -- the deepest drivers of biological aging. Glutathione is the body's most powerful antioxidant and detoxification agent, protecting cells from oxidative damage. They address different pillars of cellular health and are commonly studied together for comprehensive anti-aging protocols.
COMPARISON
Tirzepatide and NAD+ address metabolism through entirely different mechanisms. Tirzepatide acts on incretin receptors (GIP/GLP-1) to regulate appetite, insulin sensitivity, and body composition. NAD+ restores mitochondrial energy production and activates sirtuin longevity pathways. Tirzepatide is the stronger choice for weight and glycaemic research; NAD+ is superior for cellular energy and systemic aging endpoints.
COMPARISON
The NovaDose NAD+ pen offers a higher-dose, prefilled format for researchers running intensive NAD+ protocols or requiring maximum convenience. The standard NAD+ pen provides adjustable daily dosing and a lower entry price point for flexible protocols. Both deliver the same pharmaceutical-grade NAD+ -- the choice depends on whether your research prioritises dosing intensity and convenience (NovaDose) or flexibility and daily control (standard pen).
COMPARISON
Glutathione is the body's frontline defence against oxidative damage -- the direct cause of cellular aging. NAD+ powers the cellular repair machinery that reverses age-related decline -- mitochondria, sirtuins, and DNA repair enzymes. Glutathione prevents damage; NAD+ repairs it. For anti-aging research, they address the two most fundamental pillars of cellular aging and are most powerful when studied together.
ANTI-AGING
12-16 weeksCellular Rejuvenation & Skin Remodeling Stack
WELLNESS
12-16 weeksNeuroprotection & Cognitive Function Research
ANTI-AGING
16-24 weeksCellular Energy & Antioxidant Defense for Healthy Aging
WELLNESS
8-12 weeksPhase II Detoxification & Cellular Cleansing
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme in every cell that drives energy production, DNA repair, and gene regulation via sirtuins. Cellular NAD+ levels decline approximately 50% between ages 40-60, impairing these critical functions. Restoring NAD+ is a primary focus of longevity research, with studies showing reversal of age-related dysfunction in animal models.
NAD+ is an essential electron carrier in glycolysis, the citric acid cycle, and the mitochondrial electron transport chain — the three stages of cellular energy (ATP) production. Without adequate NAD+, cells cannot efficiently convert nutrients into energy, leading to mitochondrial dysfunction and metabolic decline.
Sirtuins (SIRT1-7) are NAD+-dependent enzymes that regulate DNA repair, gene expression, mitochondrial health, and inflammatory pathways. They consume NAD+ as a substrate during their activity, meaning their function directly depends on NAD+ availability. Declining NAD+ levels with age impair sirtuin activity, contributing to age-related disease.
ORYN offers NAD+ in two delivery systems: the Peptide Pen (500mg, 30-day precision dosing) and the NovaDose cartridge system (500mg, daily microdosing). Both deliver pharmaceutical-grade NAD+ with near 100% bioavailability, providing a more affordable and convenient alternative to IV NAD+ infusions.
NovaDose is ORYN's advanced cartridge-based pen delivery system for pharmaceutical-grade NAD+ (500 mg). It uses replaceable cartridges in a reusable aluminium pen body, designed for precise daily microdosing via subcutaneous injection. The system is engineered to deliver near-100% bioavailability while being more cost-effective and convenient than IV NAD+ infusions.
The standard ORYN NAD+ Pen is a single-unit pen containing 500 mg in 3 mL for 30-day use. NovaDose uses a reusable pen body with replaceable cartridges, offering a more sustainable and cost-effective long-term system. The cartridge format also allows for easier storage and transport of refills. Both deliver pharmaceutical-grade NAD+ at >99% purity.
NovaDose is administered via daily subcutaneous microdoses using the cartridge pen system. Load a cartridge into the pen body, attach a micro-needle, dial the dose, and inject. The precision dosing mechanism ensures consistent delivery with each administration. Micro-needles are included with the system.
NovaDose delivers NAD+ via subcutaneous injection, providing near-100% bioavailability. This is a significant advantage over oral NAD+ precursors (NMN, NR), which must undergo enzymatic conversion and suffer GI degradation, and even over IV infusions, which require clinical settings and significant time commitment.
RESEARCH PURPOSES ONLY. All content on this page is intended for informational and educational purposes for qualified researchers. ORYN products are not approved as medicines and are not intended for human therapeutic use. Do not use ORYN products for self-administration. Consult relevant regulations in your jurisdiction.